A model for radiation-related cancer suggested by atomic bomb survivor data

Radiation Research

Volumn 152, Issue 6, 1999, Pages 642-654

  Pierce, Donald A ^a   Mendelsohn, Mortimer L ^b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; ATOMIC BOMB; CANCER RISK; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; RADIATION EXPOSURE; STATISTICAL MODEL; STATISTICAL PARAMETERS;

EID: 0032764027     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580260     Document Type: Article

References (19)

1. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (Suppl.), S17-S67 (1994).
2. D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat. Res. 146, 1-27 (1996).
3. P. Armitage and R. Doll, The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer VIII, 1-12 (1954).
4. A. Whittemore and J. B. Keller, Quantitative theories of carcinogenesis. SIAM Rev. 20, 1-30 (1978).
5. M. L. Mendelsohn, A Simple Reductionist Model for Cancer Risk in Atom Bomb Survivors. CR 1-96, Radiation Effects Research Foundation, Hiroshima, 1996.
6. M. L. Mendelsohn and D. A. Pierce, Biomarkers and mechanisms of human radiation carcinogenesis. In Biomarkers: Medical and Workplace Applications (M. L. Mendelsohn, L. C. Mohr and J. P. Peeters, Eds.), pp. 337-344. Joseph Henry Press, Washington, D.C., 1998.
7. M. L. Mendelsohn and D. A. Pierce, A multi-stage model for cancer based on age-time patterns of radiation effects: 2. Biological aspects. In Proceedings of the International Conference on Low Doses of Ionizing Radiation: Biological Effects and Regulatory Control, pp. 123-133. IAEA, Vienna, 1998.
8. R. Doll, The age distribution of cancer: Implications for models of carcinogenesis. J. R. Stat. Soc. A 132, 133-166 (1971).
9. A. M. Kellerer and D. Barclay, Age dependencies in the modeling of radiation carcinogenesis. Radiat. Prot. Dosim. 41, 273-281 (1992).
10. S. H. Moolgavkar and A. G. Knudson, Jr., Mutation and cancer: A model for human carcinogenesis. J. Natl Cancer Inst. 66, 1037-1052 (1981).
11. S. H. Moolgavkar and E. G. Luebeck, Two-event model for carcinogenesis: Biological, mathematical, and statistical considerations. Risk Anal. 10, 323-341 (1990).
12. M. Kai, E. G. Luebeck and S. H. Moolgavkar, Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat. Res. 148, 348-358 (1997).
13. D. C. Thomas, A model for dose rate and duration of exposure effects in radiation carcinogenesis. Environ. Health Perspect. 87, 162-171 (1990).
14. M. P. Little, M. M. Hawkins, M. W. Charles and C. G. Hildreth, Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer rates. Radiat. Res. 132, 207-221 (1992).
15. M. P. Little, Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon and Knudson, and of the multistage model of Armitage and Doll. Biometrics 51, 1278-1291 (1995).
16. M. P. Little, Generalizations of the two-mutation and classical models of carcinogenesis fitted to the Japanese atomic bomb survivor data. Radiat. Prot. Dosim. 16, 7-24 (1996).
17. P. Armitage, A note on the time-homogeneous birth process. J. R. Stat. Soc. Ser. B 15, 90-91 (1953).
18. R. J. M. Fry, Experimental radiation carcinogenesis: What have we learned? Radiat. Res. 87, 224-239 (1981).
19. G. Casella and R. L. Berger, Statistical Inference. Duxbury Press, Belmont, CA, 1990.